登录  注册

肿瘤学学术中心

2016 CCO实践指南:利妥昔单抗治疗淋巴瘤和慢性淋巴细胞白血病

Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline

发布时间:2017-1-20

The systematic review process was developed by the CCO-PEBC. The PEBC is supported by the Ontario Ministry of Health and Long-term Care. All work produced by the PEBC is editorially independent from the Ministry. This evidentiary base is composed of three parts: the evidentiary base of Version 2, the results of the updated search executed in March 2012 and the content of a further update executed in October 2013. Each of the searches was developed using a planned two-stage method and this document reports the methods used for the most recent update; methods for previous versions are very similar and are available upon request. The working group of the Hematology DSG comprising physicians with content expertise, epidemiologists and consumers developed this evidentiary base upon which these guideline recommendations are based.

全文地址:
顶一下(0

发表评论

 热门指南  more

学科影响因子排名more

 会议回顾 more

  • 【专题】2015年美国临床肿瘤大会...

  • 多模式防治 改善肿瘤患者生存

  • 第13届St. Gallen国际乳...

 热门病例 more

Elsevier中国网站
爱唯医学网
爱思唯尔科技部
NursingChina
柳叶刀中文版
大通医疗决策
医大爱思唯尔
Elsevier医学数据库
CK
Journal Consult
Procedures_CONSULT
ClinicalPharmacologyLogo
3D Interact Anatomy
Mosby’s Nursing Consult
NursingChina
Science Direct